These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33739353)

  • 21. Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort.
    Lackenby A; Elliot AJ; Powers C; Andrews N; Ellis J; Bermingham A; Thompson C; Galiano M; Large S; Durnall H; Fleming D; Smith G; Zambon M
    J Antimicrob Chemother; 2013 Oct; 68(10):2324-31. PubMed ID: 23759670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
    Kang SJ; Park KH; Kee SJ; Shin JH; Jung SI; Kwon YS; Jang HC
    Jpn J Infect Dis; 2013; 66(5):425-7. PubMed ID: 24047743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
    Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
    N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A (H1N1) virus-induced hepatocellular injury in a kidney transplant patient.
    Daudé M; Mansuy JM; Guitard J; Basse G; Esposito L; Izopet J; Rostaing L; Kamar N
    Transpl Infect Dis; 2011 Feb; 13(1):70-2. PubMed ID: 20649943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.
    Flight WG; Bright-Thomas R; Mutton K; Webb K; Jones A
    BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
    Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
    Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.
    Bragstad K; Hungnes O; Litleskare I; Nyrerød HC; Dorenberg DH; Hauge SH
    Influenza Other Respir Viruses; 2019 Jul; 13(4):372-381. PubMed ID: 30834715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza.
    Wells Q; Hardin B; Raj SR; Darbar D
    Heart Rhythm; 2010 Oct; 7(10):1454-7. PubMed ID: 20656063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.
    Tarbet EB; Vollmer AH; Hurst BL; Barnard DL; Furuta Y; Smee DF
    Arch Virol; 2014 Jun; 159(6):1279-91. PubMed ID: 24311151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
    Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
    Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
    Esposito S; Molteni CG; Colombo C; Daleno C; Daccò V; Lackenby A; Principi N
    J Clin Virol; 2010 May; 48(1):62-5. PubMed ID: 20335065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mania in a patient with H1N1: is oseltamivir the culprit or a red herring?
    Khandaker GM; Khandaker GM; Dibben C; Zurynski Y; Elliott EJ; Booy R
    Am J Psychiatry; 2010 Sep; 167(9):1129-30; author reply 1130. PubMed ID: 20826864
    [No Abstract]   [Full Text] [Related]  

  • 38. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Household transmissibility and other characteristics of seasonal oseltamivir-resistant influenza A(H1N1) viruses, Germany, 2007-8.
    Buchholz U; Brockmann S; Duwe S; Schweiger B; an der Heiden M; Reinhardt B; Buda S
    Euro Surveill; 2010 Feb; 15(6):. PubMed ID: 20158979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.